| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/06/1999 | US5891851 Antibiotic, feglymycin, processes for its preparation and its use |
| 04/06/1999 | US5891850 Saccular collagen and compositions and methods for making and using the same |
| 04/06/1999 | US5891849 Methods and formulations for preventing progression of neuropathic pain |
| 04/06/1999 | US5891848 Peptide fragments |
| 04/06/1999 | US5891847 Treatment of degenerative eye disorders |
| 04/06/1999 | US5891846 Oil in water emulsion |
| 04/06/1999 | US5891845 Drug delivery systems utilizing liquid crystal structures |
| 04/06/1999 | US5891844 Compositions for treating IRDS and ARDS with a combination of a Glucocorticosteroid and a lung surfactant, and their use |
| 04/06/1999 | US5891843 Pharmaceutical composition for the treatment of blood coagulation diseases, methods for the production thereof and its use |
| 04/06/1999 | US5891842 Methodology for eliciting an analgesic response in a living subject |
| 04/06/1999 | US5891841 Methods of using intercellular adhesion molecule-3 (ICAM-3), antibodies thereto, and soluble fragments thereof |
| 04/06/1999 | US5891840 Stabilization of somatotropins by modification of cysteine residues utilizing site directed mutagenesis |
| 04/06/1999 | US5891724 Transfecting cell with hybrid nucleic acid |
| 04/06/1999 | US5891720 Isolated DNA encoding a novel human G-protein coupled receptor |
| 04/06/1999 | US5891719 Cell signal transduction |
| 04/06/1999 | US5891716 An isolated nucleic acid comprising a nucleotide sequence encoding a peptide having at least one epitope recognized by a t cell receptor specific for allergen canis familiaris i or ii; medical diagnosis; antiallergens |
| 04/06/1999 | US5891706 Hybridoma cell line; therapy and diagnosis of autoimmune skin disorders, antitumor agents |
| 04/06/1999 | US5891704 Method to produce high levels of methioninase |
| 04/06/1999 | US5891700 Receptor-type phosphotyrosine phosphatase-γ |
| 04/06/1999 | US5891684 Base-modified enzymatic nucleic acid |
| 04/06/1999 | US5891680 Dna molecule encoding an active il-12 fusion protein with at least two polypeptide monomers linked by heterologous polypeptide linker; stimulates ifn-alpha production, enhances antitumor immunity and cell mediated immunity |
| 04/06/1999 | US5891679 TNF-alpha muteins and a process for preparing them |
| 04/06/1999 | US5891678 Isolated polynucleotide encoding bacterial enzyme involved in mediating protein secretion; treatment of invasive infections and toxigenic diseases; antibiotic screening and development |
| 04/06/1999 | US5891675 TNF receptor death domain ligand proteins |
| 04/06/1999 | US5891674 The use of these sequences in the diagnosis, prevention, and treatment of cancer, inflammation, and disorders associated with insulin response. |
| 04/06/1999 | US5891673 Lck binding protein |
| 04/06/1999 | US5891672 Polynucleotides encoding GTP cyclohydrolase II (ribA) |
| 04/06/1999 | US5891670 Tetracycline resistance protein |
| 04/06/1999 | US5891667 SpoIIIe polynucleotides |
| 04/06/1999 | US5891664 Vectors and methods for recombinant production of uPA-binding fragments of the human urokinase-type plasminogen receptor (uPAR) |
| 04/06/1999 | US5891653 Immunomodulators for tissue transplants; contacting antigen presenting cells with purified stress proteins bound to an antigen; in vitro treatment of allograft, xenografts rejections in humans and animals |
| 04/06/1999 | US5891652 Methods of using domains of extracellular region of human platelet-derived growth factor receptor polypeptides |
| 04/06/1999 | US5891650 Kinase receptor activation assay |
| 04/06/1999 | US5891639 Telomerase activity assays |
| 04/06/1999 | US5891638 A method of detecting alk-7 nucleic acid or polypeptide in a sample; and kits containing nucleic acid probes or antibodies. |
| 04/06/1999 | US5891628 Identification of polycystic kidney disease gene, diagnostics and treatment |
| 04/06/1999 | US5891478 Composition for sustained release of human growth hormone |
| 04/06/1999 | US5891459 Arginine, lysine and salts with nutrients for nitric oxide intermediates |
| 04/06/1999 | US5891438 Method for stimulating production of variable region gene family restricted antibodies through B-cell superantigen vaccination |
| 04/06/1999 | US5891437 Antigen associated with type I diabetes mellitus |
| 04/06/1999 | US5891436 The present invention thus provides the basis of an extremely sensitive and specific diagnostic elisa for anti-70 kd antibodies found in pbc. |
| 04/06/1999 | US5891435 Antidiabetic agents and antigens |
| 04/06/1999 | US5891434 Monoclonal antibodies to the APO-1 antigen |
| 04/06/1999 | US5891430 Diabetogene rad: a type II diabetes specific gene |
| 04/06/1999 | US5891429 Recombinant human granulocyte-macrophage-colony stimulating factor (GM-CSF) |
| 04/06/1999 | US5891341 Compositions and devices for partitioning advanced glycosylation endproducts, and methods of their use |
| 04/06/1999 | US5891083 Suction lipolysis |
| 04/06/1999 | CA2228084A1 Agent for promoting proliferation of hematopoietic stem cells |
| 04/06/1999 | CA2155005C Pharmaceutical compositions containing bactericidal permeability increasing protein and a surfactant |
| 04/06/1999 | CA2095836C Cytokine immunoconjugates |
| 04/06/1999 | CA2074320C Process for the preparation of microspheres made of a biodegradable polymeric material |
| 04/06/1999 | CA1340485C Peptide analogs and their use as haptens to elicit catalytic antibodies |
| 04/06/1999 | CA1340483C Diagnosis of retinoblastoma |
| 04/01/1999 | WO1999015703A1 Inhibition of an fgf-binding protein using ribozymes |
| 04/01/1999 | WO1999015677A1 Method for gene transfer using bcl2 and compositions useful therein |
| 04/01/1999 | WO1999015675A1 HUMAN COMPLEMENT C3-DEGRADING PROTEINASE FROM $i(STREPTOCOCCUS PNEUMONIAE) |
| 04/01/1999 | WO1999015671A1 Hepatitis b virus polypeptides |
| 04/01/1999 | WO1999015666A2 Macrophage derived chemokine (mdc), mdc analogs, mdc inhibitor sustances, and uses thereof |
| 04/01/1999 | WO1999015665A2 Mutants of thyroid stimulating hormone and methods based thereon |
| 04/01/1999 | WO1999015662A1 Telomere repeat binding factors and diagnostic and therapeutic use thereof |
| 04/01/1999 | WO1999015661A1 Cell growth regulator |
| 04/01/1999 | WO1999015659A2 Human ubiquitin-conjugating enzymes |
| 04/01/1999 | WO1999015658A2 Human regulatory molecules |
| 04/01/1999 | WO1999015657A2 53bp2 complexes |
| 04/01/1999 | WO1999015656A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 04/01/1999 | WO1999015655A1 Dna vaccination against cholesterol ester transfer protein in the treatment of atherosclerosis |
| 04/01/1999 | WO1999015654A2 Tie receptor tyrosine kinase ligand homologues |
| 04/01/1999 | WO1999015653A2 Tie ligand homologues |
| 04/01/1999 | WO1999015652A1 Megsin protein |
| 04/01/1999 | WO1999015651A1 Synthetic polypeptide for diagnosing and treating prion-related diseases |
| 04/01/1999 | WO1999015649A2 Composition and method for enhancing paracellular transport across cell layers |
| 04/01/1999 | WO1999015648A1 Antisense oligonucleotides against thymidylate synthase |
| 04/01/1999 | WO1999015643A2 ANTISENSE OLIGONUCLEOTIDE COMPOSITIONS TARGETED TO ANGIOTENSI N CONVERTING ENZYME mRNA AND METHODS OF USE |
| 04/01/1999 | WO1999015642A1 Lunasin peptides |
| 04/01/1999 | WO1999015637A1 Fibrin microbeads and uses thereof |
| 04/01/1999 | WO1999015635A1 Human ste20-like stress activated serine/threonine kinase |
| 04/01/1999 | WO1999015626A1 Identification of hop-1 and uses thereof |
| 04/01/1999 | WO1999015562A1 Method for purification of antithrombin iii |
| 04/01/1999 | WO1999015561A1 Inhibitors of hematopoietins interleukin-3, interleukin-5 and granulocyte/macrophage colony stimulating factor and uses thereof |
| 04/01/1999 | WO1999015560A1 Soluble polypeptide having a delta-serrate-lag2 domain of delta homologue and uses thereof |
| 04/01/1999 | WO1999015559A1 Novel gene defective in apeced and its use |
| 04/01/1999 | WO1999015557A1 Malaria polypeptides |
| 04/01/1999 | WO1999015556A1 Huchordin and uses thereof |
| 04/01/1999 | WO1999015555A1 Car receptors and related molecules and methods |
| 04/01/1999 | WO1999015554A2 Ras-like protein |
| 04/01/1999 | WO1999015553A2 Costimulating t-cell polypeptide, monoclonal antibodies, their preparation and use |
| 04/01/1999 | WO1999015552A1 Oligopeptide compounds |
| 04/01/1999 | WO1999015550A1 Ucp3 genes |
| 04/01/1999 | WO1999015548A2 Isolated and recombinant antimicrobial peptides thrombocidin-1 (tc-1) and thrombocidin-2 (tc-2) or variants thereof |
| 04/01/1999 | WO1999015544A1 NUCLEOTIDE AND AMINO ACID SEQUENCES OF THE brx GENE AND GENE PRODUCT, AND USES THEREOF |
| 04/01/1999 | WO1999015198A2 Agents for combating bacterial meningitis |
| 04/01/1999 | WO1999015197A1 Preparation for the therapy of disorders related to blood clotting |
| 04/01/1999 | WO1999015196A1 Pharmaceutical substance containing various vitamin k-dependent factors |
| 04/01/1999 | WO1999015195A1 Veterinary medicine containing native or modified equine chorionic gonadotropin |
| 04/01/1999 | WO1999015194A1 Combination therapy for eradicating detectable hcv-rna in patients having chronic hepatitis c infection |
| 04/01/1999 | WO1999015193A1 LIQUID INTERFERON-β FORMULATIONS |
| 04/01/1999 | WO1999015192A1 Neuronal rescue agent |
| 04/01/1999 | WO1999015191A2 Cytokines having neurotrophic activity |
| 04/01/1999 | WO1999015190A1 Transgenic autologous t-cell therapy in humans, and related compositions and kits |
| 04/01/1999 | WO1999015169A1 Thrombin inhibitors |